About 410 Medical
410 Medical is a private company based in Durham, North Carolina. It has reported $58,479,074 raised in eight offerings on Form D since January 2015. Its chief executive is Kyle Chenet.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 15, 2026 | $10,323,798of $12.0M target | 11 | $938K | EquityRule 506(b) | Form D ↗ |
| Oct 26, 2022 | Nov 10, 2022amended Mar 18, 2025 | $25,687,994of $30.1M target | 44 | $583K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 20, 2021 | Dec 29, 2021 | $3,087,500of $5.0M target | 25 | $123K | DebtRule 506(b) | Form D ↗ |
| Oct 21, 2019 | Oct 29, 2019 | $7,600,000of $8.0M target | 21 | $361K | EquityRule 506(b) | Form D ↗ |
| Aug 7, 2018 | Aug 22, 2018 | $3,085,437of $4.0M target | 12 | $257K | DebtRule 506(b) | Form D ↗ |
| Mar 17, 2017 | Mar 31, 2017amended Jun 29, 2017 | $5,350,417of $6.5M target | 35 | $152K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 12, 2016 | Apr 22, 2016amended Sep 8, 2016 | $2,243,928fully sold | 18 | $124K | Equity, DebtRule 506(b) | Form D/A ↗2 earlier filings |
| Dec 22, 2014 | Jan 13, 2015 | $1,100,000fully sold | 6 | $183K | EquityRule 506(b) | Form D ↗ |
| Total, eight offerings | $58,479,074 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on 410 Medical's Form D filed Jul 15, 2026.
Earlier filings also listed Stanley Lynall (director, last listed Mar 2025), Jeff Terrell (director, last listed Mar 2025), Lukas Roush (director, last listed Dec 2021), John Tushar (director, last listed Oct 2019), Galen Robertson (executive officer, last listed Oct 2019), Travis Whitfill (director, last listed Aug 2018), Mike Liddell (director, last listed Jun 2017) and Larry Miller (director, last listed Jun 2017).